Title : Perceived Impact of Covid-19 Pandemic on Clinical Care and Treatment of Tuberculosis-Directly Observed Treatment Short-Course (TB-DOTS) Patients

Vol 7 No 5 (2024): Volume 07 Issue 05 May 2024

Article Date Published : 27 May 2024 | Page No.: 3190-3204 | Google Scholar | Crossref doi for this article

Abstract :

The study determined the perceived impact of the COVID-19 pandemic on the clinical care and treatment of TB-DOTS patients in Claver, Surigao del Norte, Philippines, from 2020 to 2022. The research utilized a quantitative approach through a descriptive survey, with 150 respondents through purposive sampling. Most respondents were male, and a notable proportion had completed high school. The analysis employed descriptive statistical tools, showing a positive attitude toward the financial aspects of compliance and heightened awareness of COVID-19 preventive measures. Despite challenges introduced by the pandemic, such as difficulties attending medication refill appointments, TB-DOTS patients generally expressed satisfaction with Claver’s healthcare facilities, there are variations based on educational attainment and occupation. These variations suggest the need for tailored interventions to address the specific needs and challenges of different groups of patients. Additionally, the impact of the COVID-19 pandemic on healthcare services and medication refill appointments is evident. To mitigate the impact of COVID-19 on TB services, health authorities in the Philippines collaborated with key stakeholders to ramp up and adopt easy-to-implement solutions. One solution was home-visit treatment with the help of health workers.

Keywords :

Clinical care and treatment, Communicable disease, COVID-19 pandemic, Philippines., Quantitative Research Survey, Surigao, Tb-DOTS, Tuberculosis

References :

  1. Akter, S., Chauhan, K. S., Dunlap, M. D., Choreño-Parra, J. A., Lu, L., Esaulova, E., Zúñiga, J., Artyomov, M. N., Kaushal, D., & Khader, S. A. (2022). Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes. Cell Reports, 39(12), 110983. https://www.sciencedirect.com/science/article/pii/S2211124722007690
  2. Asadi, H., Gouya, M. M., Nabavi, M., & Norouzinejad, A. (2019). The communicable diseases surveillance system in Iran: Challenges and opportunities. Archives of Iranian Medicine, 22(7). http://eprints.lums.ac.ir/2345/
  3. Atkins, S., Heimo, L., Carter, D., Closa, M. R., Vanleeuw, L., Chenciner, L., Wambi, P., Sidney-Annerstedt, K., Egere, U., Verkuijl, S., Brands, A., Masini, T., Viney, K., Wingfield, T., Lönnroth, K., & Boccia, D. (2022). The socioeconomic impact of tuberculosis on children and adolescents: A scoping review and conceptual framework. BMC Public Health, 22, https://doi.org/10.1186/s12889-022-14579-7
  4. Barnett, M. L., Mehrotra, A., & Landon, B. E. (2020). Covid-19 and the upcoming financial crisis in health care. NEJM Catal Innov Care Deliv, 1, 2. https://doi.org/CAT.20.0153
  5. Barter, D. M., Agboola, S. O., Murray, M. B., & Bärnighausen, T. (2012). Tuberculosis and poverty: The contribution of patient costs in sub-Saharan Africa – A systematic review. BMC Public Health, 12, https://doi.org/10.1186/1471-2458-12-980
  6. Beauchamp, T. (2019). The Principle of Beneficence in Applied Ethics. The Stanford Encyclopedia of Philosophy. Edward N. Zalta (Ed.). https://plato.stanford.edu/archives/spr2019/entries/principle-beneficence/
  7. Calderon, J. S., Perry, K. E., Thi, S. S., & Stevens, L. L. (2022). Innovating tuberculosis prevention to achieve universal health coverage in the Philippines. The Lancet Regional Health-Western Pacific, 100609. https://www.sciencedirect.com/science/article/pii/S2666606522002243
  8. Centers for Disease Control and Prevention. (n.d.). Global Tuberculosis (TB) and COVID-19. https://www.cdc.gov/globalhivtb/who-we-are/about-us/globaltb/globaltbandcovid19.html
  9. Centers for Disease Control and Prevention. (n.d.). TB 101 – Transmission and Pathogenesis of TB. The Centers for Disease Control and Prevention (CDC). https://www.cdc.gov/tb/webcourses/TB101/page16413.html
  10. Chilot, D., Woldeamanuel, Y., & Manyazewal, T. (2021). Real-Time Impact of COVID-19 on Clinical Care and Treatment of Patients with Tuberculosis: A Multicenter Cross-Sectional Study in Addis Ababa, Ethiopia. Annals of Global Health, 87(1), 109. https://doi.org/10.5334/aogh.3481
  11. Connolly, M., & Nunn, P. (1996). Women and tuberculosis. World Health Statistics Quarterly. Rapport Trimestriel de Statistiques Sanitaires Mondiales, 49(2), 115-119. https://europepmc.org/article/med/9050189
  12. Dadras, O., Alinaghi, S. A. S., Karimi, A., MohsseniPour, M., Barzegary, A., Vahedi, F., Pashaei, Z., Mirzapour, P., Fakhfouri, A., Zargari, G., Saeidi, S., Mojdeganlou, H., Badri, H., Qaderi, K., Behnezhad, F., & SeyedAlinaghi, S. (2021). Effects of COVID-19 prevention procedures on other common infections: A systematic review. European Journal of Medical Research, 26(1). https://doi.org/10.1186/s40001-021-00539-1
  13. Department of Health (n.d.). About NTP. National Tuberculosis Program. https://ntp.doh.gov.ph/about-ntp/
  14. Di Renzo, L., Gualtieri, P., Cinelli, G., Bigioni, G., Soldati, L., Attinà, A., Bianco, F. F., Caparello, G., Camodeca, V., Carrano, E., Ferraro, S., Giannattasio, S., Leggeri, C., Rampello, T., Lo Presti, L., Tarsitano, M. G., & De Lorenzo, A. (2020). Psychological Aspects and Eating Habits during COVID-19 Home Confinement: Results of EHLC-COVID-19 Italian Online Survey. Nutrients, 12(7), 2152. doi: 3390/nu12072152
  15. Duarte, R., Aguiar, A., Pinto, M., Furtado, I., Tiberi, S., Lönnroth, K., & Migliori, G. B. (2021). Different disease, same challenges: social determinants of tuberculosis and COVID-19. Pulmonology, 27(4), 338-344. https://www.sciencedirect.com/science/article/pii/S2531043721000489
  1. Dulock, H. L. (1993). Research design: Descriptive research. Journal of Pediatric Oncology Nursing, 10(4), 154-157.
  2. Edemekong, P. F. Huang, B. (2022, May 22). Epidemiology of Prevention of Communicable Diseases. StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470303/
  3. Ederio, N., Inocian, E., Calaca, N., & Espiritu, J.G. (2023). Ethical research practices in educational institutions: A literature review. International Journal of Current Science Research and Review, 06(5), 2709-2724. DOI:  https://doi.org/10.47191/ijcsrr/V6-i5-02
  1. Feldman, C. H., & Ramsey-Goldman, R. (2020). Widening Disparities Among Patients With Rheumatic Diseases in the COVID-19 Era: An Urgent Call to Action. Arthritis Rheumatol, 72(9), 1409-1411. https://doi.org/10.1002/art.41306
  2. Foster, N., Vassall, A., Cleary, S., Cunnama, L., Churchyard, G., & Sinanovic, E. (2015). The economic burden of TB diagnosis and treatment in South Africa. Social Science & Medicine, 130, 42-50. https://doi.org/10.1016/j.socscimed.2015.01.046
  1. Gupta, A., Singla, R., Caminero, J. A., Singla, N., Mrigpuri, P., & Mohan, A. (2020). Impact of COVID-19 on tuberculosis services in India. International Journal of Tuberculosis and Lung Disease, 24(6), 637–639. https://doi.org/10.5588/ijtld.20.0212
  2. Harries, A. D., Kumar, A. M. V., Satyanarayana, S., Lin, Y., Takarinda, K. C., Tweya, H., & Zachariah, R. (2015). Communicable and non-communicable diseases: connections, synergies and benefits of integrating care. Public health action, 5(3), 156-157. https://www.ingentaconnect.com/content/iuatld/pha/2015/00000005/00000003/art00002
  3. Hayden, J. C., & Parkin, R. (2020). The challenges of COVID-19 for community pharmacists and opportunities for the future. Irish Journal of Psychological Medicine, 37(3), 198–203. https://doi.org/10.1017/ipm.2020.52
  4. Hertz, D., & Schneider, B. (2019). Sex differences in tuberculosis. Seminars in Immunopathology, 41, 225–237. https://doi.org/10.1007/s00281-018-0725-6
  5. Hogan, A. B., Jewell, B. L., Sherrard-Smith, E., Vesga, J. F., Watson, O. J., Whittaker, C., Hamlet, A., Smith, J. A., Winskill, P., Verity, R., Baguelin, M., Lees, J. A., Whittles, L. K., Ainslie, K. E. C., Bhatt, S., Boonyasiri, A., Brazeau, N. F., Cattarino, L., Cooper, L. V., Coupland, H., &Walker, P. G. T. (2020). Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: A modeling study [published correction appears in Lancet Global Health. January 2021; 9(1): e23]. Lancet Global Health, 8(9), e1132–e1141. https://doi.org/10.1016/S2214-109X(20)30288-6
  6. Jarde, A., Romano, E., Afaq, S., Elsony, A., Lin, Y., Huque, R., Elsey, H., Siddiqi, K., Stubbs, B., & Siddiqi, N. (2022). Prevalence and risks of tuberculosis multimorbidity in low-income and middle-income countries: A meta-review. British Medical Journal Open, 12(9), e060906. https://doi.org/10.1136/bmjopen-2022-060906
  7. Kaiser, K. (2009). Protecting Respondent Confidentiality in Qualitative Research. Qualitative Health Research, 19, 1632-1641. https://doi.org/10.1177/1049732309350879
  8. Khabibullina, N. F., Kutuzova, D. M, Burmistrova, I. A., & Lyadova, I. V. (2022). The biological and clinical aspects of a latent tuberculosis infection. Tropical Medicine and Infectious Disease, 7(3), 48. https://www.mdpi.com/2414-6366/7/3/48
  9. Lee, M., Kang, B. A., & You, M. (2021). Knowledge, attitudes, and practices (KAP) toward COVID-19: A cross-sectional study in South Korea. BMC Public Health, 21, 295. https://doi.org/10.1186/s12889-021-10285-y
  10. Louie, J. K., Reid, M., Stella, J., Agraz-Lara, R., Graves, S., Chen, L., & Hopewell, P. (2020). A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic. International Journal of Tuberculosis and Lung Disease, 24(8), 860–862. doi: 5588/ijtld.20.0364
  11. Lung Center of the Philippines. (n.d.). Directly Observed Therapy (DOT) TB DOTS. https://lcp.gov.ph/directly-observed-therapy-tb-dots/
  12. Menzies, N. A., Quaife, M., Allwood, B. W., Byrne, A. L., Coussens, A. K., Harries, A. D., Marx, F. M., Meghji, J., Pedrazzoli, D., Salomon, J. A., Sweeney, S., van Kampen, S. C., Wallis, R. S., Houben, R. M. G. J., & Cohen, T. (2021). Lifetime burden of disease due to incident tuberculosis: A global reappraisal including post-tuberculosis sequelae. The Lancet Global Health, 9(12), e1679-e1687. https://www.sciencedirect.com/science/article/pii/S2214109X21003673
  13. Querri, A., Ohkado, A., Yoshimatsu, S., Coprada, L., Lopez, E., Medina, A., Garfin, A., Bermejo, J., Tang, F., & Shimouchi, A. (2017, December 21). Enhancing tuberculosis patient detection and care through community volunteers in the urban poor, The Philippines. Public Health Action, 7(4), 268-274. doi: 10.5588/pha.17.0036
  14. Querri, A., Ohkado, A., Yoshimatsu, S., Coprada, L., Lopez, E., Medina, A., Garfin, A., Bermejo, J., Tang, F., & Shimouchi, A. (2017). Enhancing tuberculosis patient detection and care through community volunteers in the urban poor, The Philippines. Public Health Action, 7(4), 268-274. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753779/
  15. Romualdez, A. G. (2007). TB-DOTS in the Philippines: Impact of decentralization and health sector reform. Bulletin of the World Health Organization, 85(5), 399–400. https://doi.org/10.2471/06.036285
  16. Tannenbaum, C., Greaves, L., & Graham, I. D. (2016). Why sex and gender matter in implementation research. BMC Medical Research Methodology, 16(1), 145. https://doi.org/10.1186/s12874-016-0247-7
  17. (2023, June 7). Smart pillboxes and mobile technology to support TB treatment. https://unitaid.org/project/smart-pillboxes-and-mobile-technology-to-support-tb-treatment/#en
  18. Vanleeuw, L., Zembe-Mkabile, W., & Atkins, S. (2022). Falling through the cracks: Increased vulnerability and limited social assistance for TB patients and their households during COVID-19 in Cape Town, South Africa. PLOS Global Public Health, 2(7), e0000708. https://doi.org/10.1371/journal.pgph.0000708
  19. Visca, D., Ong, C.W.M., Tiberi, S., Centis, R., D’Ambrosio, L., Chen, B., Mueller, J., Mueller, P., Duarte, R., Dalcolmo, M., Sotgiu, G., Migliori, G.B., & Goletti, D. (2021). Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology, 27(2), 151-165. https://www.sciencedirect.com/science/article/pii/S2531043721000040
  1. Wang, Q., Guo, S., Wei, X., Dong, Q., Xu, N., Li, H., Liu, Y., Zhang, J., & Sun, Q. (2022). Global prevalence, treatment, and outcome of tuberculosis and COVID-19 coinfection: A systematic review and meta-analysis (from November 2019 to March 2021). British Medical Journal Open, 12(6), e059396. https://bmjopen.bmj.com/content/12/6/e059396.abstract
  2. Wilson, J., Bak, A., Whitfield, A., Dunnett, A., & Loveday, H. (2017). Public perceptions of the use of gloves by healthcare workers and comparison with perceptions of student nurses. Journal of Infection Prevention, 18(3), 123–132. https://doi.org/10.1177/1757177416680442
  3. World Health Organization (WHO). (n.d.). Tuberculosis. https://www.who.int/health-topics/tuberculosis
  4. World Health Organization. (2020). Coronavirus. https://www.who.int/health-topics/coronavirus#tab=tab_1
  5. World Health Organization. (2020). Tuberculosis and COVID-19 COVID-19: Considerations for tuberculosis (TB) care. https://www.who.int/docs/default-source/documents/tuberculosis/infonote-tb-covid-19.pdf
  6. World Health Organization. (2021). Donors making a difference – Slowing down transmission. https://www.who.int/news-room/feature-stories/detail/donors-making-a-difference14_Dec_21#:~:text=Face%20masks%20are%20a%20key,Bakyaita%2C%20WHO%20Representative%20to%20Zambia
  7. World Health Organization. (2022). WHO operational handbook on tuberculosis: module 3: diagnosis: tests for tuberculosis infection. https://apps.who.int/iris/bitstream/handle/10665/363335/9789240058347-eng.pdf?sequence=1
  8. World Health Organization. (2022, October 27) Tuberculosis (TB). https://www.who.int/news-room/fact-sheets/detail/tuberculosis
  9. World Health Organization. (n.d.). 2 national surveys of costs faced by TB patients and their households. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022/uhc-tb-determinants/6-2-national-surveys-of-costs-faced-by-tb-patients-and-their-households
  10. World Health Organization. (n.d.). Tuberculosis and COVID-19: Frequently Asked Questions (FAQs). https://www.who.int/docs/default-source/documents/tuberculosis/infonote-tb-covid-19.pdf
  11. World Health Organization. (n.d.). Who consolidated guidelines on tuberculosis: Module 4: Treatment: Drug-susceptible tuberculosis treatment. https://apps.who.int/iris/handle/10665/44165

How to Cite :

Perceived Impact of Covid-19 Pandemic on Clinical Care and Treatment of Tuberculosis-Directly Observed Treatment Short-Course (TB-DOTS) Patients. Christine Rose A. Olvez, Eunice Anne E. Guibao, Frytzel L. Mejia, Carmel Grace B. Guazon, Nikko T. Ederio , 7(5), 3190-3204. Retrieved from https://ijcsrr.org/single-view/?id=16496&pid=15990

Most read articles by the same author(s)

Christine Rose A. Olvez, Eunice Anne E. Guibao, Frytzel L. Mejia, Carmel Grace B. Guazon, Nikko T. Ederio,

View

72

Citation

Downloads

Article Details